Invitrogen™ Human AVEN Synthetic Peptide
Aven Synthetic Peptide, PEP-0405, from Invitrogen.
- Gene ID (Enter)
- 57099
- Species
- Human
- Purification method
- Purified
- Accession number
- Q9NQS1
- Common name
- Human AVEN
- Brand
- Invitrogen
Aven Synthetic Peptide, PEP-0405, from Invitrogen.
Aven Synthetic Peptide, PEP-0405, from Invitrogen.
Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells. Disruption of this process has been implicated in a variety of diseases such as cancer. Aven is a recently discovered protein that blocks apoptosis induced by Apaf-1 and caspase-9. It is thought that Aven functions by binding to Bcl-xL, an antiapoptotic member of the Bcl-2 family, and to Apaf-1, possibly interfering with the ability of Apaf-1 to self-associate, suggesting that Aven impedes Apaf-1-mediated caspase activation. Higher levels of Aven mRNA are seen in patients with acute leukemia than in control patients, suggesting that Aven may be useful as a prognostic indicator in leukemia patients.
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15226619 |
| Specifications | |
| Gene ID (Enter) | 57099 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q9NQS1 |
| Common name | Human AVEN |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | AVEN |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-0405 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 96 00 |